Folgen
Joerg Striessnig
Joerg Striessnig
Bestätigte E-Mail-Adresse bei uibk.ac.at - Startseite
Titel
Zitiert von
Zitiert von
Jahr
International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels
WA Catterall, E Perez-Reyes, TP Snutch, J Striessnig
Pharmacological reviews 57 (4), 411-425, 2005
15752005
Purification, molecular cloning, and expression of the mammalian sigma1-binding site.
M Hanner, FF Moebius, A Flandorfer, HG Knaus, J Striessnig, E Kempner, ...
Proceedings of the National Academy of Sciences 93 (15), 8072-8077, 1996
11381996
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels
J Platzer, J Engel, A Schrott-Fischer, K Stephan, S Bova, H Chen, ...
Cell 102 (1), 89-97, 2000
10462000
The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential
GW Zamponi, J Striessnig, A Koschak, AC Dolphin
Pharmacological reviews 67 (4), 821-870, 2015
10192015
Neurobiology of migraine
D Pietrobon, J Striessnig
Nature Reviews Neuroscience 4 (5), 386-398, 2003
7702003
Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity
ME Mangoni, B Couette, E Bourinet, J Platzer, D Reimer, J Striessnig, ...
Proceedings of the National Academy of Sciences 100 (9), 5543-5548, 2003
5642003
α1D (Cav1. 3) subunits can form L-type Ca2+ channels activating at negative voltages
A Koschak, D Reimer, I Huber, M Grabner, H Glossmann, J Engel, ...
Journal of Biological Chemistry 276 (25), 22100-22106, 2001
5492001
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
EAB Azizan, H Poulsen, P Tuluc, J Zhou, MV Clausen, A Lieb, C Maniero, ...
Nature genetics 45 (9), 1055-1060, 2013
5262013
Pharmacological disruption of calcium channel trafficking by the α2δ ligand gabapentin
J Hendrich, AT Van Minh, F Heblich, M Nieto-Rostro, K Watschinger, ...
Proceedings of the National Academy of Sciences 105 (9), 3628-3633, 2008
4862008
Receptor sites for Ca2+ channel antagonists
WA Catterall, J Striessnig
Trends in pharmacological sciences 13, 256-262, 1992
4771992
CaV1. 3 channels are essential for development and presynaptic activity of cochlear inner hair cells
A Brandt, J Striessnig, T Moser
Journal of Neuroscience 23 (34), 10832-10840, 2003
4482003
The Concise Guide to PHARMACOLOGY 2019/20: Introduction and other protein targets
SPH Alexander, E Kelly, A Mathie, JA Peters, EL Veale, JF Armstrong, ...
British journal of pharmacology 176, S1-S20, 2019
4092019
Functional embryonic cardiomyocytes after disruption of the L-type α1C (Cav 1.2) calcium channel gene in the mouse
C Seisenberger, V Specht, A Welling, J Platzer, A Pfeifer, S Kuhbandner, ...
Journal of Biological Chemistry 275 (50), 39193-39199, 2000
3762000
Loss of Cav1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness
SM Baig, A Koschak, A Lieb, M Gebhart, C Dafinger, G Nürnberg, A Ali, ...
Nature neuroscience 14 (1), 77-84, 2011
3492011
International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels
WA Catterall, J Striessnig, TP Snutch, E Perez-Reyes
Pharmacological reviews 55 (4), 579-581, 2003
3472003
The concise guide to pharmacology 2019/20: Ion channels
SPH Alexander, A Mathie, JA Peters, EL Veale, J Striessnig, E Kelly, ...
British journal of pharmacology 176, S142-S228, 2019
3382019
Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons
A Tottene, T Fellin, S Pagnutti, S Luvisetto, J Striessnig, C Fletcher, ...
Proceedings of the National Academy of Sciences 99 (20), 13284-13289, 2002
3322002
Familial Hemiplegic Migraine Mutations Change α1ACa2+ Channel Kinetics
RL Kraus, MJ Sinnegger, H Glossmann, S Hering, J Striessnig
Journal of Biological Chemistry 273 (10), 5586-5590, 1998
329*1998
Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain
CS Müller, A Haupt, W Bildl, J Schindler, HG Knaus, M Meissner, ...
Proceedings of the National Academy of Sciences 107 (34), 14950-14957, 2010
3242010
Structural basis of drug binding to L Ca2+ channels
J Striessnig, M Grabner, J Mitterdorfer, S Hering, MJ Sinnegger, ...
Trends in pharmacological sciences 19 (3), 108-115, 1998
3211998
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20